相似文献
1
Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors.
Medchemcomm. 2017 Dec 1;9(1):149-159. doi: 10.1039/c7md00457e. eCollection 2018 Jan 1.
2
Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Bioorg Chem. 2019 Aug;89:103006. doi: 10.1016/j.bioorg.2019.103006. Epub 2019 May 21.
3
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
J Enzyme Inhib Med Chem. 2018 Dec;33(1):496-506. doi: 10.1080/14756366.2018.1430691.
4
Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.
Eur J Med Chem. 2015 Mar 6;92:799-806. doi: 10.1016/j.ejmech.2015.01.044. Epub 2015 Jan 22.
5
Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl- and Thioxo-1,2,4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors.
ISRN Pharmacol. 2012;2012:707932. doi: 10.5402/2012/707932. Epub 2012 Aug 16.
6
Conjugates of Tacrine and Its Cyclic Homologues with p-Toluenesulfonamide as Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
Dokl Biochem Biophys. 2018 Nov;483(1):369-373. doi: 10.1134/S1607672918060200. Epub 2019 Jan 3.
7
Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
Eur J Med Chem. 2017 Jan 5;125:1200-1212. doi: 10.1016/j.ejmech.2016.11.008. Epub 2016 Nov 8.
8
Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Bioorg Chem. 2016 Feb;64:13-20. doi: 10.1016/j.bioorg.2015.11.002. Epub 2015 Nov 10.
9
Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Med Chem. 2017;13(7):648-653. doi: 10.2174/1573406413666170306113347.
10
Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation.
Comput Struct Biotechnol J. 2021 Aug 3;19:4517-4537. doi: 10.1016/j.csbj.2021.07.041. eCollection 2021.
引用本文的文献
1
Novel Lawsone-Quinoxaline Hybrids as New Dual Binding Site Acetylcholinesterase Inhibitors.
ACS Omega. 2023 Aug 29;8(36):32498-32511. doi: 10.1021/acsomega.3c02683. eCollection 2023 Sep 12.
2
An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities.
Pharmaceuticals (Basel). 2023 Jan 24;16(2):179. doi: 10.3390/ph16020179.
3
Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase.
RSC Adv. 2022 Jul 12;12(31):19764-19855. doi: 10.1039/d2ra03081k. eCollection 2022 Jul 6.
4
Design, synthesis and biological evaluation of novel -phosphorylated and -phosphorylated tacrine derivatives as potential drugs against Alzheimer's disease.
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1012-1022. doi: 10.1080/14756366.2022.2045591.
5
Isolation, Characterization and In Silico Studies of Secondary Metabolites from the Whole Plant of Peşmen & Erik.
Molecules. 2022 Jan 21;27(3):684. doi: 10.3390/molecules27030684.
6
Dual acting oximes designed for therapeutic decontamination of reactive organophosphates catalytic inactivation and acetylcholinesterase reactivation.
RSC Med Chem. 2021 Aug 4;12(9):1592-1603. doi: 10.1039/d1md00194a. eCollection 2021 Sep 23.
7
Synthesis of Biologically Relevant 1,2,3- and 1,3,4-Triazoles: From Classical Pathway to Green Chemistry.
Molecules. 2021 Sep 18;26(18):5667. doi: 10.3390/molecules26185667.
8
Chromenol Derivatives as Novel Antifungal Agents: Synthesis, In Silico and In Vitro Evaluation.
Molecules. 2021 Jul 16;26(14):4304. doi: 10.3390/molecules26144304.
9
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors.
Curr Neuropharmacol. 2021;19(8):1323-1344. doi: 10.2174/1570159X19666201218103434.
10
: a source for anti-Alzheimer's disease drugs.
Pharm Biol. 2020 Dec;58(1):410-416. doi: 10.1080/13880209.2020.1758732.
本文引用的文献
1
Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
Curr Med Chem. 2017;24(32):3522-3546. doi: 10.2174/0929867324666170309123920.
2
The worldwide costs of dementia 2015 and comparisons with 2010.
Alzheimers Dement. 2017 Jan;13(1):1-7. doi: 10.1016/j.jalz.2016.07.150. Epub 2016 Aug 29.
3
Discovery of novel anti-HIV agents via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approach.
Expert Opin Drug Discov. 2016 Sep;11(9):857-71. doi: 10.1080/17460441.2016.1210125. Epub 2016 Jul 21.
4
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
J Med Chem. 2016 Jan 14;59(1):114-31. doi: 10.1021/acs.jmedchem.5b01119. Epub 2015 Dec 29.
5
Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries.
Drug Discov Today. 2016 Jan;21(1):118-132. doi: 10.1016/j.drudis.2015.08.004. Epub 2015 Aug 24.
6
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities.
Expert Opin Drug Discov. 2015 May;10(5):449-61. doi: 10.1517/17460441.2015.1032936. Epub 2015 Apr 2.
7
Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem. 2015 Jan 7;89:349-61. doi: 10.1016/j.ejmech.2014.10.018. Epub 2014 Oct 18.
8
Design and synthesis of 8-hydroxyquinoline-based radioprotective agents.
Bioorg Med Chem. 2014 Aug 1;22(15):3891-905. doi: 10.1016/j.bmc.2014.06.017. Epub 2014 Jun 18.
9
From single target to multitarget/network therapeutics in Alzheimer's therapy.
Pharmaceuticals (Basel). 2014 Jan 23;7(2):113-35. doi: 10.3390/ph7020113.
10
Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
PLoS One. 2013 Sep 16;8(9):e73478. doi: 10.1371/journal.pone.0073478. eCollection 2013.
Zotero 插件